Why Shares Of Moderna Soared [Seeking Alpha]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Seeking Alpha
Summary Moderna posted strong quarterly results. Stock buying intensified as speculators searched for COVID-19 vaccine developers. With billions in addressable market, long-term prospects look bright. Moderna's MRNA Moderna posted earnings per share of negative 37 cents, beating consensus press release Progress in mRNA-1647 and mRNA-1273 Moderna said that "two of three dose cohorts in Phase 2 CMV vaccine (mRNA-1647) dose-confirmation study completed enrollment." Phase 2 analysis of results in the third quarter of 2020 should shed some light on the cytomegalovirus efficacy. The company began shipping a batch of novel coronavirus vaccine (mRNA-1273) to the National Institutes of Health ("NIH"). It expedited the shipment of the clinical materials in just 42 days. The phase 1 study, along with another five new development candidate studies, lowers the speculation risks for investors. The more studies Moderna has that is fully funded with its $2 billion, the better chances it has in bringi
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- U.K. Tests World-First Personalized Skin Cancer Vaccine [Forbes]Forbes
- Should You Buy Moderna Before May 12? [Yahoo! Finance]Yahoo! Finance
- Sunil Wadhwa Joins Kong as Chief Customer Officer [Yahoo! Finance]Yahoo! Finance
- Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/22/24 - Beat
MRNA
Sec Filings
- 4/26/24 - Form 4
- 4/24/24 - Form 144
- 4/19/24 - Form 4
- MRNA's page on the SEC website